Search bioRxivSearch

Biology subjects

Seitz, F.

Publications and source records attributed to Seitz, F..

2 recordsLinked to original sources

Sugar transporters enable a leaf beetle to accumulate plant defense compounds

Many herbivorous insects selectively accumulate plant toxins for defense against predators; however, little is known about the transport processes that enable insects to absorb and store defense compounds in the body. Here, we investigate how a specialist herbivore, the horseradish flea beetle, accumulates high amounts of glucosinolate defense compounds in the hemolymph. Using phylogenetic analyses of coleopteran membrane transporters of the major facilitator superfamily, we identified a clade of glucosinolate-specific transporters (PaGTRs) belonging to the sugar porter family. PaGTR expression was predominantly detected in the excretory system, the Malpighian tubules. Silencing of PaGTRs led to elevated glucosinolate excretion, significantly reducing the levels of sequestered glucosinolates in beetles. This suggests that PaGTRs reabsorb glucosinolates from the Malpighian tubule lumen to prevent their loss by excretion. Ramsay assays performed with dissected Malpighian tubules confirmed a selective retention of glucosinolates. Thus, the selective accumulation of plant defense compounds in herbivorous insects can depend on the ability to prevent excretion.

physiology

Mechanism of SARS-CoV-2 polymerase inhibition by remdesivir

Remdesivir is the only FDA-approved drug for the treatment of COVID-19 patients1-4. The active form of remdesivir acts as a nucleoside analogue and inhibits the RNA-dependent RNA polymerase (RdRp) of coronaviruses including SARS-CoV-25-7. Remdesivir is incorporated by the RdRp into the growing RNA product and allows for addition of three more nucleotides before RNA synthesis stalls6,8. Here we use synthetic RNA chemistry, biochemistry and cryo-electron microscopy to establish the molecular mechanism of remdesivir-induced RdRp stalling. We show that addition of the fourth nucleotide following remdesivir incorporation into the RNA product is impaired by a barrier to further RNA translocation. This translocation barrier causes retention of the RNA 3-nucleotide in the substrate-binding site of the RdRp and interferes with entry of the next nucleoside triphosphate, thereby stalling RdRp. In the structure of the remdesivir-stalled state, the 3-nucleotide of the RNA product is matched with the template base, and this may prevent proofreading by the viral 3-exonuclease that recognizes mismatches9,10. These mechanistic insights should facilitate the quest for improved antivirals that target coronavirus replication.

biochemistry